Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 1;15:1398135. doi: 10.3389/fphar.2024.1398135

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2024 Oliveira, De Oliveira, Bráz, Oliveira, Lima-Santos and Dias.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Fa-CI plot of combined treatments of ExtTa with DOX in Saos-2 osteosarcoma cells and with 5-FU in HCT116 colorectal cancer cells. The combination index was calculated using CompuSyn software. Dose-effect curve for ExtTa + DOX (A) and ExtTa + 5-FU (E); Median-effect plot for ExtTa + DOX (B) and ExtTa + 5-FU (F). Combination index (CI) for ExtTa + DOX (C) and ExtTa + 5-FU (G); Dose-reduction index (DRI) for the combination of the ExtTa + DOX (D) and ExtTa + 5-FU (H). Fa, fraction affected; ExtTa, Ethanolic Extract T. asperelloides; DOX, doxorubicin; ExtDOX, combined treatments of Ethanolic Extract T. asperelloides and doxorubicin; 5-FU, 5-fluorouracil; Ext5FU, combined treatments of Ethanolic Extract T. asperelloides and 5-fluorouracil.